Literature DB >> 21207190

Adjuvant 5-fluorouracil-induced colitis necessitating completion colectomy.

Sunil J Amonkar1, Henry J Cain, Tracey Hughes, J Diane Hemming, David A Browell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21207190     DOI: 10.1007/s12029-010-9241-1

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  8 in total

1.  Colitis associated to chemotherapy with 5-fluorouracil.

Authors:  F Trevisani; M Simoncini; G Alampi; M Bernardi
Journal:  Hepatogastroenterology       Date:  1997 May-Jun

Review 2.  Pseudomembranous colitis leading to toxic megacolon associated with antineoplastic chemotherapy. Report of a case and review of the literature.

Authors:  V Velanovich; A J LaPorta; W L Garrett; T B Richards; P A Cornett
Journal:  Dis Colon Rectum       Date:  1992-04       Impact factor: 4.585

3.  Fulminant Clostridium difficile colitis associated with paclitaxel and carboplatin chemotherapy.

Authors:  E. Resnik; C. A. Lefevre
Journal:  Int J Gynecol Cancer       Date:  1999-11       Impact factor: 3.437

4.  Pseudomembranous colitis associated with chemotherapy with 5-fluorouracil.

Authors:  Rafael Morales Chamorro; Raquel Serrano Blanch; María José Méndez Vidal; María Auxiliadora Gómez España; María Jesús Rubio Pérez; Juan Rafael de la Haba Rodríguez; Enrique Aranda Aguilar
Journal:  Clin Transl Oncol       Date:  2005-07       Impact factor: 3.405

5.  Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment.

Authors:  F Saliba; R Hagipantelli; J L Misset; G Bastian; G Vassal; M Bonnay; P Herait; C Cote; M Mahjoubi; D Mignard; E Cvitkovic
Journal:  J Clin Oncol       Date:  1998-08       Impact factor: 44.544

6.  Colitis in patients with breast carcinoma treated with taxane-based chemotherapy.

Authors:  Zhiyong Li; Nuhad K Ibrahim; Jay K Wathen; Michael Wang; Rosario P Mante Menchu; Vicente Valero; Richard Theriault; Aman U Buzdar; Gabriel N Hortobagyi
Journal:  Cancer       Date:  2004-10-01       Impact factor: 6.860

7.  Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer.

Authors:  Fairooz Kabbinavar; Herbert I Hurwitz; Louis Fehrenbacher; Neal J Meropol; William F Novotny; Grazyna Lieberman; Susan Griffing; Emily Bergsland
Journal:  J Clin Oncol       Date:  2003-01-01       Impact factor: 44.544

8.  Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea.

Authors:  J A Maroun; L B Anthony; N Blais; R Burkes; S D Dowden; G Dranitsaris; B Samson; A Shah; M P Thirlwell; M D Vincent; R Wong
Journal:  Curr Oncol       Date:  2007-02       Impact factor: 3.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.